Oral Proteins and Peptides Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1066685
  • May 2021
  • Pharmaceuticals
  • 132 Pages
The global Oral Proteins and Peptides market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Oral Proteins and Peptides market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Oral Proteins and Peptides market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Oral Proteins and Peptides market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Allergan Plc., AstraZeneca PLC, Biocon Limited, Chiasma Inc., Generex Biotechnology Corp., Novo Nordisk A/S, Oramed Pharmaceuticals Inc., Proxima Concepts Limited (Diabetology Ltd.), Synergy Pharmaceuticals Inc., Tarsa Therapeutics Inc.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Oral Proteins and Peptides market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Oral Proteins and Peptides market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Oral Proteins and Peptides market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Oral Proteins and Peptides market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Oral Proteins and Peptides Market:
The Oral Proteins and Peptides market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Allergan Plc., AstraZeneca PLC, Biocon Limited, Chiasma Inc., Generex Biotechnology Corp., Novo Nordisk A/S, Oramed Pharmaceuticals Inc., Proxima Concepts Limited (Diabetology Ltd.), Synergy Pharmaceuticals Inc., Tarsa Therapeutics Inc.

Oral Proteins and Peptides Market Segment Analysis:
By Drug Type
Octreotide
Linaclotide
Insulin
Plecanatide
Calcitonin
Application
Hormonal Disorders
Gastric and Digestive Disorders
Diabetes
Bone Diseases

Geographic Coverage for Oral Proteins and Peptides Market:
The market research report on global Oral Proteins and Peptides market offers complete analysis across various regions across the world. The Oral Proteins and Peptides market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Oral Proteins and Peptides market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Oral Proteins and Peptides Market Value and Forecast
  • US
  • Canada
Europe Oral Proteins and Peptides Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Oral Proteins and Peptides Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Oral Proteins and Peptides Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Oral Proteins and Peptides Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Oral Proteins and Peptides market report:
  • The report provides key trends of the global Oral Proteins and Peptides market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Oral Proteins and Peptides industry
  • The report covers all the recent developments of the Oral Proteins and Peptides market and helps to provide current industry updates
  • The report covers a detailed look over the global Oral Proteins and Peptides Industry and provides with significant actionable insights
  • The Oral Proteins and Peptides market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Oral Proteins and Peptides market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Oral Proteins and Peptides market
  • Comprehensive analysis of the Oral Proteins and Peptides market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Oral Proteins and Peptides market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Oral Proteins and Peptides market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Oral Proteins and Peptides market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Oral Proteins and Peptides market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Oral Proteins and Peptides market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Allergan Plc.
  • AstraZeneca PLC
  • Biocon Limited
  • Chiasma Inc.
  • Generex Biotechnology Corp.
  • Novo Nordisk A/S
  • Oramed Pharmaceuticals Inc.
  • Proxima Concepts Limited (Diabetology Ltd.)
  • Synergy Pharmaceuticals Inc.
  • Tarsa Therapeutics Inc.
  • Octreotide
  • Linaclotide
  • Insulin
  • Plecanatide
  • Calcitonin
  • Hormonal Disorders
  • Gastric and Digestive Disorders
  • Diabetes
  • Bone Diseases

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Oral Proteins and Peptides Market Snapshot
          2.1.1. Global Oral Proteins and Peptides Market By Drug Type,2019
               2.1.1.1.Octreotide
               2.1.1.2.Linaclotide
               2.1.1.3.Insulin
               2.1.1.4.Plecanatide
               2.1.1.5.Calcitonin
          2.1.2. Global Oral Proteins and Peptides Market By Application,2019
               2.1.2.1.Hormonal Disorders
               2.1.2.2.Gastric and Digestive Disorders
               2.1.2.3.Diabetes
               2.1.2.4.Bone Diseases
          2.1.3. Global Oral Proteins and Peptides Market By End-use,2019
          2.1.4. Global Oral Proteins and Peptides Market By Geography,2019

3. Global Oral Proteins and Peptides Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Oral Proteins and Peptides Market Size (US$), By Drug Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Drug Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Drug Type, 2020
     4.2. Global Oral Proteins and Peptides Market Size (US$), By Drug Type, 2018 – 2028

5. Global Oral Proteins and Peptides Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Oral Proteins and Peptides Market Size (US$), By Application, 2018 – 2028

6. Global Oral Proteins and Peptides Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Oral Proteins and Peptides Market Size (US$), By End-use, 2018 – 2028

7. Global Oral Proteins and Peptides Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Oral Proteins and Peptides Market Analysis, 2018 – 2028 
          7.2.1. North America Oral Proteins and Peptides Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Oral Proteins and Peptides Market Size (US$), By Drug Type, 2018 – 2028
          7.2.3. North America Oral Proteins and Peptides Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Oral Proteins and Peptides Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Oral Proteins and Peptides Market Analysis, 2018 – 2028 
          7.3.1.  Europe Oral Proteins and Peptides Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Oral Proteins and Peptides Market Size (US$), By Drug Type, 2018 – 2028
          7.3.3. Europe Oral Proteins and Peptides Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Oral Proteins and Peptides Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Oral Proteins and Peptides Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Oral Proteins and Peptides Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Oral Proteins and Peptides Market Size (US$), By Drug Type, 2018 – 2028
          7.4.3. Asia Pacific Oral Proteins and Peptides Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Oral Proteins and Peptides Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Oral Proteins and Peptides Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Oral Proteins and Peptides Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Oral Proteins and Peptides Market Size (US$), By Drug Type, 2018 – 2028
          7.5.3. Latin America Oral Proteins and Peptides Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Oral Proteins and Peptides Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Oral Proteins and Peptides Market Analysis, 2018 – 2028 
          7.6.1.  MEA Oral Proteins and Peptides Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Oral Proteins and Peptides Market Size (US$), By Drug Type, 2018 – 2028
          7.6.3. MEA Oral Proteins and Peptides Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Oral Proteins and Peptides Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Oral Proteins and Peptides Providers
        8.4.1 Allergan Plc.
                8.4.1.1 Business Description
                8.4.1.2 Allergan Plc. Geographic Operations
                8.4.1.3 Allergan Plc. Financial Information
                8.4.1.4 Allergan Plc. Product Positions/Portfolio
                8.4.1.5 Allergan Plc. Key Developments
        8.4.2 AstraZeneca PLC
                8.4.2.1 Business Description
                8.4.2.2 AstraZeneca PLC Geographic Operations
                8.4.2.3 AstraZeneca PLC Financial Information
                8.4.2.4 AstraZeneca PLC Product Positions/Portfolio
                8.4.2.5 AstraZeneca PLC Key Developments
        8.4.3 Biocon Limited
                8.4.3.1 Business Description
                8.4.3.2 Biocon Limited Geographic Operations
                8.4.3.3 Biocon Limited Financial Information
                8.4.3.4 Biocon Limited Product Positions/Portfolio
                8.4.3.5 Biocon Limited Key Developments
        8.4.4 Chiasma Inc.
                8.4.4.1 Business Description
                8.4.4.2 Chiasma Inc. Geographic Operations
                8.4.4.3 Chiasma Inc. Financial Information
                8.4.4.4 Chiasma Inc. Product Positions/Portfolio
                8.4.4.5 Chiasma Inc. Key Developments
        8.4.5 Generex Biotechnology Corp.
                8.4.5.1 Business Description
                8.4.5.2 Generex Biotechnology Corp. Geographic Operations
                8.4.5.3 Generex Biotechnology Corp. Financial Information
                8.4.5.4 Generex Biotechnology Corp. Product Positions/Portfolio
                8.4.5.5 Generex Biotechnology Corp. Key Developments
        8.4.6 Novo Nordisk A/S
                8.4.6.1 Business Description
                8.4.6.2 Novo Nordisk A/S Geographic Operations
                8.4.6.3 Novo Nordisk A/S Financial Information
                8.4.6.4 Novo Nordisk A/S Product Positions/Portfolio
                8.4.6.5 Novo Nordisk A/S Key Developments
        8.4.7 Oramed Pharmaceuticals Inc.
                8.4.7.1 Business Description
                8.4.7.2 Oramed Pharmaceuticals Inc. Geographic Operations
                8.4.7.3 Oramed Pharmaceuticals Inc. Financial Information
                8.4.7.4 Oramed Pharmaceuticals Inc. Product Positions/Portfolio
                8.4.7.5 Oramed Pharmaceuticals Inc. Key Developments
        8.4.8 Proxima Concepts Limited (Diabetology Ltd.)
                8.4.8.1 Business Description
                8.4.8.2 Proxima Concepts Limited (Diabetology Ltd.) Geographic Operations
                8.4.8.3 Proxima Concepts Limited (Diabetology Ltd.) Financial Information
                8.4.8.4 Proxima Concepts Limited (Diabetology Ltd.) Product Positions/Portfolio
                8.4.8.5 Proxima Concepts Limited (Diabetology Ltd.) Key Developments
        8.4.9 Synergy Pharmaceuticals Inc.
                8.4.9.1 Business Description
                8.4.9.2 Synergy Pharmaceuticals Inc. Geographic Operations
                8.4.9.3 Synergy Pharmaceuticals Inc. Financial Information
                8.4.9.4 Synergy Pharmaceuticals Inc. Product Positions/Portfolio
                8.4.9.5 Synergy Pharmaceuticals Inc. Key Developments
        8.4.10 Tarsa Therapeutics Inc.
                8.4.10.1 Business Description
                8.4.10.2 Tarsa Therapeutics Inc. Geographic Operations
                8.4.10.3 Tarsa Therapeutics Inc. Financial Information
                8.4.10.4 Tarsa Therapeutics Inc. Product Positions/Portfolio
                8.4.10.5 Tarsa Therapeutics Inc. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Oral Proteins and Peptides Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Oral Proteins and Peptides Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Oral Proteins and Peptides Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Oral Proteins and Peptides Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Oral Proteins and Peptides Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Oral Proteins and Peptides Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Oral Proteins and Peptides Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Oral Proteins and Peptides Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Oral Proteins and Peptides Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Oral Proteins and Peptides Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Oral Proteins and Peptides Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Oral Proteins and Peptides Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Oral Proteins and Peptides Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Oral Proteins and Peptides Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Oral Proteins and Peptides Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Oral Proteins and Peptides Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Oral Proteins and Peptides: Market Segmentation 
FIG. 2 Global Oral Proteins and Peptides Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Oral Proteins and Peptides Market, By Drug Type, 2019 (US$ Mn) 
FIG. 5 Global Oral Proteins and Peptides Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Oral Proteins and Peptides Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Oral Proteins and Peptides Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Oral Proteins and Peptides Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Oral Proteins and Peptides Providers, 2019
FIG. 11 Global Oral Proteins and Peptides Market Revenue Contribution, By Drug Type, 2019 & 2028 (Value %) 
FIG. 12 Global Oral Proteins and Peptides Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Oral Proteins and Peptides Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Oral Proteins and Peptides Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Oral Proteins and Peptides Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Oral Proteins and Peptides Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Oral Proteins and Peptides Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Oral Proteins and Peptides Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Oral Proteins and Peptides market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Oral Proteins and Peptides Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Oral Proteins and Peptides Market Value, By Segment1, 2018 – 2028
TABLE  North America Oral Proteins and Peptides Market Value, By Segment2, 2018 – 2028
TABLE  North America Oral Proteins and Peptides Market Value, By Country, 2018 – 2028
TABLE  Europe Oral Proteins and Peptides Market Value, By Segment1, 2018 – 2028
TABLE  Europe Oral Proteins and Peptides Market Value, By Segment2, 2018 – 2028
TABLE  Europe Oral Proteins and Peptides Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Oral Proteins and Peptides Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Oral Proteins and Peptides Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Oral Proteins and Peptides Market Value, By Country, 2018 – 2028
TABLE  Latin America Oral Proteins and Peptides Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Oral Proteins and Peptides Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Oral Proteins and Peptides Market Value, By Country, 2018 – 2028
TABLE  MEA Oral Proteins and Peptides Market Value, By Segment1, 2018 – 2028
TABLE  MEA Oral Proteins and Peptides Market Value, By Segment2, 2018 – 2028
TABLE  MEA Oral Proteins and Peptides Market Value, By Country, 2018 – 2028
TABLE  Allergan Plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AstraZeneca PLC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Biocon Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Chiasma Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Generex Biotechnology Corp.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novo Nordisk A/S: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Oramed Pharmaceuticals Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Proxima Concepts Limited (Diabetology Ltd.): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Synergy Pharmaceuticals Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Tarsa Therapeutics Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Oral Proteins and Peptides Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Oral Proteins and Peptides Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Oral Proteins and Peptides Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Oral Proteins and Peptides Market, By Geography, 2019 (US$ Mn)
FIG.  Global Oral Proteins and Peptides Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Oral Proteins and Peptides Providers, 2016
FIG.  Global Oral Proteins and Peptides Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Linaclotide Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Insulin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Plecanatide Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Calcitonin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Oral Proteins and Peptides Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Gastric and Digestive Disorders Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Diabetes Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Bone Diseases Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Oral Proteins and Peptides Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Oral Proteins and Peptides Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Oral Proteins and Peptides Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Oral Proteins and Peptides Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Oral Proteins and Peptides Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Oral Proteins and Peptides Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Oral Proteins and Peptides Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Oral Proteins and Peptides Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Oral Proteins and Peptides Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Oral Proteins and Peptides Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Oral Proteins and Peptides Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Oral Proteins and Peptides Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Oral Proteins and Peptides Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Oral Proteins and Peptides Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Oral Proteins and Peptides Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Oral Proteins and Peptides Market Value, 2018 – 2028, (US$ Mn)